encyclopedia of medical concepts
ψ 
ψ 
ψ 
ψ 

Receptors, Vasopressin

More information in Books or onNLM PubMed
Definition: Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors.  coordinate IM with specific vasopressin (IM); DF: RECEPT VASOPRESSIN    Other names Vasopressin Receptors; V2 Receptors; V1 Receptors; Receptors, V2; Receptors, V1; Antidiuretic Hormone Receptors; Vasopressin Receptor, V1b; Vascular Hepatic Type Arginine Vasopressin Recepto; V1b Receptor, Vasopressin; Renal Type Arginine Vasopressin Receptor; Receptors, Argipressin; Receptors, Antidiuretic Hormone; Receptor, Vasopressin V3; Receptor, Vasopressin V1b; Receptor, Vasopressin; Receptor, V2; Receptor, V1; Receptor, Argipressin; Receptor, Arginine Vasopressin; Receptor, Antidiuretic Hormone
 
SubstanceCAS Registry & nameCategoriesSourceDrugs*
PF-184563  0   *Benzodiazepines *Triazoles Receptors, Vasopressin/antagonists & inhibitors. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5684-7.
4-(4-(4-chlorophenyl)-5-(1,2,3)triazol-2-ylmethyl-4H-(1,2,4)triazol-3-yl)piperidin-1-yl-(3,5-difluorophenyl)methanone  0   *Triazoles *Piperidines Receptors, Vasopressin/antagonists & inhibitors. Eur J Pharmacol. 2011 Nov 30;670(2-3):347-55.
vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)  0   *Vasopressins Receptors, Vasopressin/agonists. J Pharmacol Exp Ther 2011 Jun;337(3):786-96
mozavaptan  0   *Benzamides *Benzazepines Receptors, Vasopressin/antagonists & inhibitors. Jpn J Clin Oncol 2011 Jan;41(1):148-52
vasopressin, 1-adamantaneacetyl-O-Et-Tyr(2)-Val(4)-aminobutyryl(6)-Arg(8,9)  0   Arginine Vasopressin/*analogs & derivatives Receptors, Vasopressin/antagonists & inhibitors. Neurocrit Care 2010 Feb;12(1):124-31
vasopressin, deaminoPen(1)-O-Me-Tyr(2)-Arg(8)  0   Arginine Vasopressin/*analogs & derivatives Receptors, Vasopressin/antagonists & inhibitors. Neurocrit Care 2010 Feb;12(1):124-31
VRQ397  0   *Oligopeptides Receptors, Vasopressin/antagonists & inhibitors. Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1009-18
vasopressin, Mpa(1)-Aic(2)-Val(4)-Arg(8)  0   Arginine Vasopressin/*analogs & derivatives Receptors, Vasopressin/agonists. J Med Chem 2007 Jun 14;50(12):2926-9
phenylacetyl-O-ethyltyrosyl-phenylalanyl-glutaminyl-asparagyl-lysyl-prolyl-argininamide  0   *Oligopeptides Receptors, Vasopressin/antagonists & inhibitors. Eur J Neurosci 2006 Sep;24(6):1565-74
4'-(4,4-difluoro-5-(2-oxo-2-(4-piperidinopiperidino)ethylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl)-2-methyl-3-furanilide  0   *Benzazepines *Piperidines Receptors, Vasopressin/antagonists & inhibitors. Vascul Pharmacol 2005 Jan;42(2):47-55
LSCPR2 protein, Lymnaea stagnalis  0   *Receptors, Vasopressin Signal Transduction.
5-(4-biphenyl)-3-methyl-4-(2-(6-(4-methyl-1-piperazinyl)hexyloxy)phenyl)-1,2,4-triazole  0   *Triazoles *Piperazines Receptors, Vasopressin/antagonists & inhibitors. J Med Chem 2002 Jun 6;45(12):2589-98
Nalp6 protein, rat  0   *Receptors, Angiotensin *Receptors, Vasopressin. Nat Med 1995 Oct;1(10):1074-81
4'-(4,4-difluoro-5-(2-(4-dimethylaminopiperidino)-2-oxoethylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl)-2-phenylbenzanilide  0   *Azepines *Piperidines Receptors, Vasopressin/antagonists & inhibitors. Br J Pharmacol 2001 Jul;133(5):746-54
OPC 51803  0   *Benzazepines *Pyrrolidines Receptors, Vasopressin/agonists. Br J Pharmacol 2000 Apr;129(8):1700-6
5-((4-((2-methylphenyl)carbonylamino)phenyl)carbonyl)-4,10-dhydro-5H-thieno(3,2-c)(1)benzazepine  0   *Benzazepines *Thiophenes Receptors, Vasopressin/antagonists & inhibitors. Bioorg Med Chem Lett 1999 Jul 5;9(13):1733-6
5-(((2-chloro-4-(5-fluoro-2-methylphenyl)carbonylamino)phenyl)carbonyl)-9,10-dihydro-4H-thieno(2,3-c)(1)benzazepine  0   *Benzazepines *Thiophenes Receptors, Vasopressin/antagonists & inhibitors. Bioorg Med Chem Lett 1999 Jul 5;9(13):1733-6
N-methyl-(1-(4-(2-(4-methylphenyl)benzoylamino)benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylidene)acetamide  0   *Benzamides *Benzazepines Receptors, Vasopressin/antagonists & inhibitors. Chem Pharm Bull (Tokyo) 1999 Mar;47(3):329-39
N-methyl-(1-(4-(2-methylbenzoylamino)benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylidene)acetamide  0   *Benzamides *Benzazepines Receptors, Vasopressin/antagonists & inhibitors. Chem Pharm Bull (Toyko) 1999 Mar;47(3):329-39
tolvaptan  150683-30-0   *Benzazepines Hyponatremia Receptors, Vasopressin/antagonists & inhibitors. J Pharmacol Exp Ther 1998 Dec;287(3):860-7SAMSCA
conivaptan  0   *Benzazepines Receptors, Vasopressin/antagonists & inhibitors. Eur J Pharmacol 1997 Feb 26;321(2):225-30VAPRISOL; VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
satavaptan  0   *Morpholines *Spiro Compounds Receptors, Vasopressin/antagonists & inhibitors. J Clin Invest 1996 Dec 15;98(12):2729-38
vasopressin, (beta-mercapto-(beta,beta)-cyclopentamethylenepropionic acid)-Phe(2)-Ile(4)-Ala(9)  0   *Vasopressins Receptors, Vasopressin/antagonists & inhibitors. J Endocrinol 1995 Oct;147(1):59-65
LSCPR1 protein, Lymnaea stagnalis  0   *Receptors, Vasopressin Signal Transduction. J Biol Chem. 1996 Feb 16;271(7):3619-26.; Neuron 1995 Oct;15(4):897-908
Cul5 protein, rat  0   *Receptors, Vasopressin *Cullin Proteins Arginine Vasopressin. Am J Physiol 1995 Jun;268(6 Pt 2):F1198-1210
OPC 31260  137975-06-5 Benzamide, N-(4-((5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methyl  *Benzazepines Receptors, Vasopressin/antagonists & inhibitors. Br J Pharmacol 1992 Apr;105(4):787-91
OPC 21268  131631-89-5 Acetamide, N-(3-(4-((4-(3,4-dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl)carbonyl)phenoxy)propyl)  *Piperidines *Quinolones Receptors, Vasopressin/antagonists & inhibitors. Science 1991;252(5005):572
vasotocin receptor  0   *Receptors, Vasopressin. Fed Proc 1982;41(8):2365
lysine-vasopressin receptors  0   *Receptors, Vasopressin Lypressin. J Biol Chem 1981;256(7):3415

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy